Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Moffitt Cancer Center 's new mobile unit will deploy into communities Non-invasive, low-dose CT scanner onboard American Lung Association: Lung cancer is the leading cause of cancer death overall ...

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).